# Kineta Immuno-Oncology, LLC — Form D/A

Kineta Immuno-Oncology, LLC of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2017-06-13. The offering totals $1.5M, of which $238K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-06-13
- Form: D/A
- Accession: 0001682247-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $238K
- Remaining: $1.3M
- Investors: 6
- Date of first sale: 2016-08-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-268881

## Issuer

- Name: Kineta Immuno-Oncology, LLC
- CIK: 0001682247
- Entity type: Limited Liability Company
- Jurisdiction: WASHINGTON
- Incorporated: 2016
- Address: 219 TERRY AVENUE N., SEATTLE, WA, 98109-5208
- Phone: 206-378-0400

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Shawn Iadonato | Director | Seattle, WA |
| Shawn Iadonato | Executive Officer | Seattle, WA |
| Robert Hedequist | Executive Officer | Seattle, WA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-08-03](https://search.stillhousedata.com/formd/0001682247-17-000003) | D | — | $9K |
| [2016-08-12](https://search.stillhousedata.com/formd/0001682247-16-000002) | D | $1.5M | $238K |

## More

- [CIK 1682247 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1682247&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001682247-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.